Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -1.60% | +1.65% | -18.54% |
Financials (USD)
Sales 2024 * | 745M | Sales 2025 * | 796M | Capitalization | 871M |
---|---|---|---|---|---|
Net income 2024 * | -259M | Net income 2025 * | -222M | EV / Sales 2024 * | 1.17 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
-3.37
x | P/E ratio 2025 * |
-4.79
x | Employees | 3,930 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.01% |
Latest transcript on OPKO Health, Inc.
1 day | -1.60% | ||
1 week | +1.65% | ||
Current month | +2.50% | ||
1 month | +27.51% | ||
3 months | +23.00% | ||
6 months | -2.38% | ||
Current year | -18.54% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Adam Logal
DFI | Director of Finance/CFO | 46 | 07-02-28 |
Elias Zerhouni
PSD | President | 72 | 22-05-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Roger Medel
BRD | Director/Board Member | 77 | 20-12-17 |
Director/Board Member | 68 | 07-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.07% | 509 M€ | -.--% | ||
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.23 | -1.60% | 6,062,547 |
24-04-23 | 1.25 | +1.63% | 2,387,338 |
24-04-22 | 1.23 | 0.00% | 3,627,063 |
24-04-19 | 1.23 | 0.00% | 2,666,432 |
24-04-18 | 1.23 | -1.60% | 4,096,872 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.54% | 871M | |
-16.65% | 8.36B | |
+39.98% | 3.6B | |
-32.00% | 2.87B | |
-7.71% | 2.47B | |
-9.65% | 2.24B | |
-13.29% | 1.81B | |
-19.46% | 1.56B | |
-40.57% | 1.23B | |
+9.70% | 1.13B |
- Stock Market
- Equities
- OPK Stock